Calcium folinate pentahydrate
High Grade Serous Ovarian Cancer
Institute of Cancer Research, United KingdomSmall moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 89/ 100
Competitive context
9 Active assets in the High Grade Serous Ovarian Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Veliparib AbbVie | Phase 2 | BB |
Upifitamab Rilsodotin Mersana Therapeutics | Phase 3 | B |
Avutometinib University of Oklahoma | Phase 2 | CCC |
Defactinib University of Oklahoma | Phase 2 | CCC |
Vinorelbine AbbVie | Phase 1 | CCC |
View all 11 →
Same molecule, other indications
Calcium folinate pentahydrate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →